Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, are chronic conditions that significantly ...

Discover the role of biomarkers in diagnosing and managing Inflammatory Bowel Disease (IBD), including Crohn's Disease and ...

Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disorder of the gastrointestinal (GI) tract that significantly impacts the ...

Fever is a possible symptom of Crohn’s disease, as well as its complications. It’s also a possible side effect of certain ...

Researchers at the University of Jyväskylä, Finland, are developing a promising method to support the diagnosis of ...

Researchers at the University of Michigan have delved deeper into the relationship between manganese deficiency and ...

Many chronic diseases are hitting the Black community hard. Here are five diseases that you need to be aware of.

Inflammatory bowel disease (IBD) is a complex condition that extends beyond clinical symptoms, profoundly impacting patients’ ...

C4X Discovery Holdings LimitedPatientSeek identifies a genetic signature that separates a4b7 integrin therapy responder and non-responder ...

The U.S. Food and Drug Administration has allowed the expanded use of Johnson & Johnson's drug, Tremfya, to treat adults with ...

Cannabinoids are associated with decreasing disease activity and improving quality of life for individuals with Crohn disease and ulcerative colitis.

The prevalence of inflammatory bowel disease (IBD) in the United States is approximately 0.9% of the general population, with ulcerative colitis (UC) affecting 0.4% and Crohn’s disease (CD) affecting ...